If this stock fails to go higher tomorrow morning, that's not a problem. If it pulls back to to $3.49 and starts a rally from there, that's a strong indication the bullish move will continue and the stock takes out the $3.58 and hones in on $4.59- which could cause a short covering rally in days ahead, along the way. May need a contract to get it done but maybe not.
I'm not seeing any near term resistance after $3.58. It needs to be bought like crazy if it drops back to $3.37. If it should happen that way, the "substance free" posters will blather for a while but such stock action- bouncing off $3.37, would also be very bullish.
I'm in no way a short term trader but I've been calling for the $4.59 for a while- based on the nice earnings growth and profit, especially after non recurring expenses.
The action was real decent today. Don't let the mediocre volume fool you ,IMO!
I say, hold on because it's fundamentally a decent stock to own just based on MD-- but it's one with huge potential, should the M&A deal pan out.
Right now Iteris is coping quite well without it but with passage they will gain a strong tailwind.
He is right about immediate boost in revs. However this precision Ag strategy is for long term holders who will risk losing time. Time does mean $. But this is a chance to participate in a virtual start up in a bonafide hot field without the usual risks of losing 90% of your investment.
What I find exciting about the deal is, I'm becoming more of a believer. I think the CC will be great. They said that being a public company for decades gives them an edge over unknown start ups and here we have an example. This deal absolutely is not fluff. There are customers for the APIs and at this stage of a nascent market, they seem to be doing things right.
A few days ago I posted that I'm 70% confident this foray into big data analytics and Ag will be successful.
This deal ups me to 71% and I actually like that buoyant feeling of increasing confidence.
I'm super happy with this investment.
As long as revs grow at 40% or so the stock shall rise.
Traders use moving averages so that's why I picked the inflection points that I mentioned.
$4.59 coming soon enough.
Due to timing of reorders there may be one step back and two forward but I would not let that through you.
The model is sound and user base is growing. There's zero churn. Future cash flows drive price.
There will have to be validation of the ID Checker acquisition in order for us to see all time highs exceeded permanently. IMO.
Big block at $3.58. But bulls in charge. Should work back toward 52wk high.
$1.20 according to Roth's buy recommendation 8-28-2015 and price target. Ther's a lot of incentive for insiders to get it there.
Long term I'll be watching Adjusted EBITDA from continuing operations- which in the second quarter of 2015 was negative $2.4 million.
There are a variety of things in effect that can reverse that and turn the company back to profitability.
Cutting costs even more, possibly more divestitures, better focus and ramping up sales of new products.
If you know a better place to double the $ you have that's underwater, let me know. There's a new CEO and Sales VP telling us they can get us into the black.
I have orders in if it drops much more.
Looking for the $3.57 mark. Bulls still in charge.
The steady rise in revenues from MD will eventually drive away these posters with nothing much to say.
Even if there is a a low level, gradual ramp with ID Checker business deals, I think we can pretty much count on MD really hitting a stride over next 4Q's.
This alone may facilitate a return of MITK to the good graces of the big institutional buyers who, in the past drove the stock to $12.00, simply based on MD's potential
If the recent M&A comes to be seen as a proven strategy, this could also take the stock quite a way towards old highs. But that's to be seen.
This shows me that the overall Ag strategy seems to be taking on a tangible, solid form.
I'm looking for a really upbeat CC with some specifics on growth trajectories especially as far as revenue ramp goes.
This is a nice win that increases their profile - Iteris is a player in Ag, for sure.
What if they can extend API's to Sumimoto, a conglomerate with over 100 companies? Just a thought!
In 1991, Valent became a wholly owned subsidiary of Sumitomo Chemical Company, Limited.
In 1994, Valent de Mexico was established.
In 2001, Valent began marketing and selling plant growth regulators, bioinsecticides and other biorational products from Valent BioSciences Corporation—the former Ag Specialties Business Unit of Abbott Laboratories.
In 2004, Valent becomes the Sumitomo Chemical Company regional headquarters of the Americas.
In 2007 the Valent Canada - Crop and Professional Products office opened in Guelph to bring new innovation and technology to Canadian growers.
In 2009, Valent U.S.A. Corporation and Valent BioSciences Corporation aligned under common leadership.
I'm loving that and the long and short term charts all look great. My ITI also breaking out. My AXGN broke out too. $20M potential revs. from the last contract. More contracts probably coming with RMF.
Most popular to put on ignore. It's like the logic of "No one goes to that restaurant any more, it's too crowded." Funny!
D is for drivel.
Posts are worthless and not about MITK but about impugning other posters.
An empty taxi pulled up and Bob.D got out.
Calls himself Mayor of the Board and surely blathers like an empty suited politician. Can be funny every few weeks when not repeating same old lines. Otherwise, he should just leave.
It's not that far off. Needs to close over $3.38. Then it should take on $3.57. Once beyond that a short haul to recent old highs and intermediate top at $4.59 or so. That will mean a triple bottom is in and the stock will no longer be eying old lows but old highs. This will take some time but ER should not derail us as in the past. It's smoothing out and growing real steady for foreseeable future.
Next ER will have some hit to profit due to acquisition and some upgrades but I think the market is looking past that to a real upbeat CC and nice profitability after this ER and beyond to 2016. Todays PR, gas prices at $2 and generally good, USA economy,unaffected by strong USD can only help.
...to see them bring some one on board from Climate Corp., the Billion dollar corporation that Monsanto bought and that does not have a better weather prediction service or one to even match what ITERIS has in the works to go worldwide.
Market is estimated at $1.6B. Half is $800M. 10% of that is $80M.
The first clue that they feel they can be successful with their products was the hiring of sales people in spite of the cash burn. The next was the nice increase in sales last reported. But when the new Director came in with the big investment, now we know THEY must believe the AXGN products are winners.
This, IMO, is why there's no pullback when market drops. If everyone wants a pullback there won't be one.
The first 10% lump is the hardest, the next is way easier and the following few lumps will just be swept up in the clamor to go with the procedure of consensus. My hope is there will eventually be a tipping point creating a flood of sales.
(I wonder if a hospital could get sued if there's a complication from harvesting a perfectly functional nerve from a patient when the consensus is to use "off the shelf" AXGN products. I also wonder what directors would feel about the unnecessary expenses.)